Have a personal or library account? Click to login
Correlations between depression, cognitive status, functional scores, disability and lesion load in multiple sclerosis treated with interferon beta 1a Cover

Correlations between depression, cognitive status, functional scores, disability and lesion load in multiple sclerosis treated with interferon beta 1a

Open Access
|Jun 2015

References

  1. 1. Luzzio C. Multiple Sclerosis.eMedicine.Medscape. Retrieved 11/25/2014 from http://emedicine.medscape.com/article/1146199-overview
  2. 2. Reese JP, Wienemann G, John A, Linnemann A, Balzer-Geldsetzer M, Mueller UO, Eienbroker C, Tackenberg B, Dodel R. Preference-based Health status in a German outpatient cohort with multiple sclerosis. Health Qual Life Outcomes; 2013; 11:162.10.1186/1477-7525-11-162385144724089999
  3. 3. Sahraian MA, Etesam F. Cognitive Impairment in Multiple Sclerosis. ZJRMS 2014;16(1):1-7
  4. 4. Skokou M, Soubasi E, GourzisP.Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatricpopulations. ISRN Neurol. 2012;2012:427102. doi: 10.5402/2012/427102.10.5402/2012/427102347776723097716
  5. 5. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J NeurolNeurosurg Psychiatry. 2005 Apr;76(4):469-75.10.1136/jnnp.2004.054635173957515774430
  6. 6. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH.Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry. 2002 Nov;159(11):1862-8.10.1176/appi.ajp.159.11.186212411220
  7. 7. Niino M, Mifune N, Kohriyama T, Mori M, Ohashi T, Kawachi I, Shimizu Y, Fukaura H, Nakashima I, Kusunoki S, Miyamoto K, Yoshida K, Kanda T, Nomura K, Yamamura T, Yoshii F, Kira J, Nakane S, Yokoyama K, Matsui M, Miyazaki Y, Kikuchi S.Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis. BMC Neurol. 2014;14:3. doi: 10.1186/1471-2377-14-3.10.1186/1471-2377-14-3388401824393373
  8. 8. Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, Hamalainen P, Hartung HP, Krupp L, Penner IK, Reder AT, Benedict RH. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).MultScler. 2012;18(6):891-8. doi: 10.1177/1352458511431076.10.1177/1352458511431076354664222190573
  9. 9. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression.Arch Gen Psychiatry.1961;4:561-71.10.1001/archpsyc.1961.0171012003100413688369
  10. 10. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444-5210.1212/WNL.33.11.14446685237
  11. 11. Parmenter BA, Weinstock-Guttman B, Garg N, Munschauer F, Benedict RH. Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test. MultScler. 2007 Jan;13(1):52-7.10.1177/135245850607075017294611
  12. 12. Benedict RH, Duquin JA, Jurgensen S, Rudick RA, Feitcher J, Munschauer FE, Panzara MA, Weinstock-Guttman B. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler. 2008;14(7):940-6. doi: 10.1177/1352458508090923.10.1177/135245850809092318573822
  13. 13. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122:871-882.10.1093/brain/122.5.871
  14. 14. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. MultScler 1999;5(4):244-250.
  15. 15. Kanner A. Depression in Neurologic Disorders: Diagnosis and Management. August 2012, Wiley-Blackwell10.1002/9781118348093
  16. 16. Huijbregts SC, Kalkers NF, de Sonneville LM, et al. Cognitive impair ment and decline in different MS subtypes . J Neurol Sci 2006;245:187-194.10.1016/j.jns.2005.07.018
  17. 17. Whitlock FA , Siskind MM. Depression as a major symptom of multiple sclerosis. J Neurol Neurosurg Psychiatry 1980;43:861-865.10.1136/jnnp.43.10.861
  18. 18. Schubert DS, Foliart RH. Increased de pression in multiple sclerosis patients. A meta - analysis. Psychosomatics 1993;34:124-130.
  19. 19. Sadovnick AD, Remick RA, Allen J, et al. Depression and multiple sclerosis. Neurology 1996;46:628-632.10.1212/WNL.46.3.628
  20. 20. Joffe RT, Lippert GP, Gray TA, et al. Mood disorder and multiple sclerosis . Arch Neurol 1987;44:376-378.10.1001/archneur.1987.00520160018007
  21. 21. Patten SB, Beck CA, Williams JV, et al. Major depression in multiple sclerosis: a population - based perspective. Neurology 2003;61:1524-1527.10.1212/01.WNL.0000095964.34294.B4
  22. 22. Schiffer RB. Depression in neurological practice: diagnosis, treatment, implications. Semin Neurol 2009;29:220-233.10.1055/s-0029-1223873
  23. 23. Rabkin JG , Albert SM, Del Bene ML, et al. Prevalence of depressive disorders and change over time in late - stage ALS. Neurology 2005;65:62-67.10.1212/01.wnl.0000167187.14501.0c
  24. 24. Gilchrist AC, Creed FH. Depression, cognitive impair ment and social stress in multiple sclerosis. J Psychosom Res 1994. 38:193-201.10.1016/0022-3999(94)90115-5
  25. 25. Lobentanz IS , Asenbaum S, Vass K, et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand 2004;110:6 - 13.10.1111/j.1600-0404.2004.00257.x
  26. 26. Janssens AC, van Doorn PA, de Boer JB, et al. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler 2003;9:397-403.10.1191/1352458503ms930oa
  27. 27. Galeazzi GM, Ferrari S, Giaroli G, et al. Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 2005;26:255-262.10.1007/s10072-005-0468-8
  28. 28. Gay MC, Vrignaud P, Garitte C, et al. Predictors of depression in multiple sclerosis patients. Acta Neurol Scand 2010;121:161-170.10.1111/j.1600-0404.2009.01232.x
  29. 29. Dahl OP, Stordal E, Lydersen S, et al. Anxiety and depression in multiple sclerosis. A comparative population - based study in Nord - Trondelag County, Norway. Mult Scler 2009;15:1495-1501.10.1177/1352458509351542
  30. 30. Beal CC, Stuifbergen AK, Brown A. Depression in multiple sclerosis: a longitudinal analysis. Arch Psychiatr Nurs 2007;21:181-191.10.1016/j.apnu.2007.02.008
  31. 31. Zabad RK, Patten SB, Metz LM. The association of depression with disease course in multiple sclerosis. Neurology. 2005;64:359-360.10.1212/01.WNL.0000149760.64921.AA
  32. 32. Kessler RC, McGonagle KA, Swartz M, et al. Sex and depression in the National Comorbidity Survey: lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85-96.10.1016/0165-0327(93)90026-G
  33. 33. Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996;276:293-299.10.1001/jama.1996.03540040037030
  34. 34. Beiske AG , Svensson E , Sandanger I , et al. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 2008;15:239-245.10.1111/j.1468-1331.2007.02041.x18215155
  35. 35. Kneebone II, Dunmore EC, Evans E. Symptoms of depression in older adults with multiple sclerosis (MS): comparison with a matched sample of younger adults. Aging Ment Health 2003;7:182-185.10.1080/136078603100010114812775398
  36. 36. Benedict RH, Amato MP, Boringa J, et al. Brief International Cognitive Assessment for MS (BICAMS): international standards for validation. BMC Neurol 2012;16:12:55.10.1186/1471-2377-12-55360784922799620
  37. 37. Amato MP, Portaccio E, Goretti B, et al. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler 2010;16:1474-1482.10.1177/135245851038008920729256
  38. 38. Amato MP, Portaccio E, Stromillo ML, et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology 2008;71:632-638.10.1212/01.wnl.0000324621.58447.0018725589
  39. 39. Filippi M, Rocca MA, Benedict RH, et al. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010;75:2121-2128.10.1212/WNL.0b013e318200d768338542321135387
  40. 40. Wallin MT, Wilken JA, Turner AP, Williams RM, Kane R. Depression and multiple sclerosis: Review of a lethal combination. J Rehabil Res Dev 2006;43:45-62.10.1682/JRRD.2004.09.011716847771
  41. 41. Maor Y, Olmer L, Mozes B. The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients--the role of depression. Mult Scler 2001;7:131-135.
  42. 42. Krupp LB, Sliwinski M, Masur DM, Friedberg F, Coyle PK. Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis. Arch Neurol 1994;51:705-710.10.1001/archneur.1994.005401900890218018045
  43. 43. Kenealy PM, Beaumont JG, Lintern TC, Murrell RC. Autobiographical memory in advanced multiple sclerosis: assessment of episodic and personal semantic memory across three time spans. J Int Neuropsychol Soc 2002;8:855-860.10.1017/S1355617702860143
  44. 44. Feinstein A, Roy P, Lobaugh N, Feinstein K, O’Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004;62:586-590 10.1212/01.WNL.0000110316.12086.0C
DOI: https://doi.org/10.1515/amma-2015-0016 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 34 - 39
Submitted on: Dec 8, 2014
Accepted on: Jan 12, 2015
Published on: Jun 16, 2015
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Smaranda Maier, Rodica Bălașa, Z. Bajko, Anca Maier, Bianca Șchiopu, M. Buruian, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.